Dutch Intracerebral Hemorrhage Surgery Trial

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Intracerebral HemorrhageMinimally Invasive Surgical ProceduresEndoscopic Surgical Procedures
Interventions
DEVICE

Minimally invasive endoscopy-guided surgery

The devices allowed into the trial, are minimally invasive neuronavigation integrated endoscopy-guided devices that are CE approved and admissible by the steering committee. Currently, only the Artemis Neuro Evacuation Device (Penumbra Inc, Alameda, California, USA) is available and CE approved.

Trial Locations (11)

Unknown

RECRUITING

Amsterdam University Medical Center, Amsterdam

NOT_YET_RECRUITING

Medisch Spectrum Twente, Enschede

NOT_YET_RECRUITING

University Medical Center Groningen, Groningen

NOT_YET_RECRUITING

Leiden University Medical Center, Leiden

RECRUITING

Maastricht University Medical Center, Maastricht

RECRUITING

Radboud University Medical Center, Nijmegen

RECRUITING

Erasmus University Medical Center, Rotterdam

RECRUITING

Haaglanden Medical Center, The Hague

RECRUITING

Elisabeth-TweeSteden Hospital, Tilburg

RECRUITING

University Medical Center Utrecht, Utrecht

RECRUITING

Isala, Zwolle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Dutch National Health Care Institute

OTHER

collaborator

Penumbra Inc.

INDUSTRY

lead

Radboud University Medical Center

OTHER